Your browser doesn't support javascript.
loading
Overnight variation in tidal expiratory flow limitation in COPD patients and its correction: an observational study.
McKenzie, J; Nisha, P; Cannon-Bailey, S; Cain, C; Kissel, M; Stachel, J; Proscyk, C; Romano, R; Hardy, B; Calverley, P M A.
Afiliação
  • McKenzie J; Philips Respironics, Monroeville, PA, USA.
  • Nisha P; Philips Respironics, Monroeville, PA, USA.
  • Cannon-Bailey S; Philips Respironics, Monroeville, PA, USA.
  • Cain C; Philips Respironics, Monroeville, PA, USA.
  • Kissel M; Philips Respironics, Monroeville, PA, USA.
  • Stachel J; Philips Respironics, Monroeville, PA, USA.
  • Proscyk C; Philips Respironics, Monroeville, PA, USA.
  • Romano R; Philips Respironics, Monroeville, PA, USA.
  • Hardy B; Philips Respironics, Monroeville, PA, USA.
  • Calverley PMA; Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK. pmacal@liverpool.ac.uk.
Respir Res ; 22(1): 319, 2021 Dec 23.
Article em En | MEDLINE | ID: mdl-34949190
BACKGROUND: Tidal expiratory flow limitation (EFLT) is common among COPD patients. Whether EFLT changes during sleep and can be abolished during home ventilation is not known. METHODS: COPD patients considered for noninvasive ventilation used a ventilator which measured within-breath reactance change at 5 Hz (∆Xrs) and adjusted EPAP settings to abolish EFLT. Participants flow limited (∆Xrs > 2.8) when supine underwent polysomnography (PSG) and were offered home ventilation for 2 weeks. The EPAP pressure that abolished EFLT was measured and compared to that during supine wakefulness. Ventilator adherence and subjective patient perceptions were obtained after home use. RESULTS: Of 26 patients with supine EFLT, 15 completed overnight PSG and 10 the home study. In single night and 2-week home studies, EFLT within and between participants was highly variable. This was unrelated to sleep stage or body position with only 14.6% of sleep time spent within 1 cmH2O of the awake screening pressure. Over 2 weeks, mean EPAP was almost half the mean maximum EPAP (11.7 vs 6.4 cmH2O respectively). Group mean ∆Xrs was ≤ 2.8 for 77.3% of their home use with a mean time to abolish new EFLT of 5.91 min. Adherence to the ventilator varied between 71 and 100% in prior NIV users and 36-100% for naïve users with most users rating therapy as comfortable. CONCLUSIONS: Tidal expiratory flow limitation varies significant during sleep in COPD patients. This can be controlled by auto-titrating the amount of EPAP delivered. This approach appears to be practical and well tolerated by patients. TRIAL REGISTRATION: The trial was retrospectively registered at CT.gov NCT04725500.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Volume de Ventilação Pulmonar / Polissonografia / Doença Pulmonar Obstrutiva Crônica / Expiração / Ventilação não Invasiva Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Volume de Ventilação Pulmonar / Polissonografia / Doença Pulmonar Obstrutiva Crônica / Expiração / Ventilação não Invasiva Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos